Pipeline
Developing novel small molecule drug candidates in the inflammation & immunology space
Our Science
Early Discovery
Late Discovery
IND-Enabling
Phase I
Brd4
Systemic indications (oral)
Late Discovery
Brd4
Cutaneous indications (topical)
Late Discovery
Brd4
Ophthalmic indications
Early Discovery
Undisclosed Transcription Factor
Inflammation/immune indications
Early Discovery
4 Undisclosed
Inflammation/immune indications
Early Discovery